Trials / Completed
CompletedNCT04904055
Evaluating the Impact of a Value-based Prescription Drug Formulary
Value-based Formulary-Essentials: Testing and Expanding on Value in Prescription Drug Benefit Design
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 36,333 (actual)
- Sponsor
- Kaiser Permanente · Academic / Other
- Sex
- All
- Age
- 0 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medication use, emergency department visits, hospitalizations, and outpatient office visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Value-based Formulary | Prescription drug formulary tiers informed by estimated value |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2021-05-27
- Last updated
- 2021-05-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04904055. Inclusion in this directory is not an endorsement.